marketcaparena
Search

    Xtant Medical Holdings, Inc.

    XTNT

    Revenue · TTM
    $110M-14.3% YoY
    Gross profit · TTM
    $65M-15.4% YoY59.4% margin
    Operating income · TTM
    $-10.5M-37582.1% YoY-9.6% margin
    Free cash flow · TTM
    —Four comparable prior quarters required for growth
    Employees 151Market cap $49.91MUpdated 2026-09-29Company website
    About Xtant Medical Holdings, Inc.

    Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

    Operating metrics

    The measures behind the business.

    No operating metrics are currently published for this company.

    Revenue mix

    What the company sells, and where.

    Revenue by geography

    Quarterly · USD

    Stacked periods reconcile exactly to reported revenue. Periods with missing or overlapping categories are left blank.

    Values & sources
    PeriodPeriod endUSDSource
    United States · Q1 262026-03-3120,707,0000001493152-26-022604
    International · Q1 262026-03-31177,0000001493152-26-022604
    United States · Q3 252025-09-3030,312,0000001493152-25-021512
    International · Q3 252025-09-302,943,0000001493152-25-021512
    United States · Q2 252025-06-3032,133,0000001641172-25-023120
    Rest of World · Q2 252025-06-303,278,0000001641172-25-023120
    United States · Q1 252025-03-3130,117,0000001493152-26-022604
    International · Q1 252025-03-312,787,0000001493152-26-022604
    United States · Q4 242024-12-3128,768,000Source unavailable
    Rest of World · Q4 242024-12-312,746,000Source unavailable
    United States · Q3 242024-09-3025,342,0000001493152-25-021512
    International · Q3 242024-09-302,595,0000001493152-25-021512
    United States · Q2 242024-06-3026,276,0000001641172-25-023120
    Rest of World · Q2 242024-06-303,667,0000001641172-25-023120
    United States · Q1 242024-03-3125,133,0000001641172-25-009674
    Rest of World · Q1 242024-03-312,740,0000001641172-25-009674

    Geography growth

    Q1 25 to Q1 26

    Same fiscal period one year apart.

    Values & sources
    PeriodPeriod endUSDSource
    United States · Q1 262026-03-3120,707,0000001493152-26-022604
    International · Q1 262026-03-31177,0000001493152-26-022604
    United States · Q3 252025-09-3030,312,0000001493152-25-021512
    International · Q3 252025-09-302,943,0000001493152-25-021512
    United States · Q2 252025-06-3032,133,0000001641172-25-023120
    Rest of World · Q2 252025-06-303,278,0000001641172-25-023120
    United States · Q1 252025-03-3130,117,0000001493152-26-022604
    International · Q1 252025-03-312,787,0000001493152-26-022604
    United States · Q4 242024-12-3128,768,000Source unavailable
    Rest of World · Q4 242024-12-312,746,000Source unavailable
    United States · Q3 242024-09-3025,342,0000001493152-25-021512
    International · Q3 242024-09-302,595,0000001493152-25-021512
    United States · Q2 242024-06-3026,276,0000001641172-25-023120
    Rest of World · Q2 242024-06-303,667,0000001641172-25-023120
    United States · Q1 242024-03-3125,133,0000001641172-25-009674
    Rest of World · Q1 242024-03-312,740,0000001641172-25-009674

    Revenue around the world

    Q1 26 · USD

    Fiji: no separately mapped disclosureTanzania: no separately mapped disclosureW. Sahara: no separately mapped disclosureCanada: no separately mapped disclosureUnited States of America: $20.7MKazakhstan: no separately mapped disclosureUzbekistan: no separately mapped disclosurePapua New Guinea: no separately mapped disclosureIndonesia: no separately mapped disclosureArgentina: no separately mapped disclosureChile: no separately mapped disclosureDem. Rep. Congo: no separately mapped disclosureSomalia: no separately mapped disclosureKenya: no separately mapped disclosureSudan: no separately mapped disclosureChad: no separately mapped disclosureHaiti: no separately mapped disclosureDominican Rep.: no separately mapped disclosureRussia: no separately mapped disclosureBahamas: no separately mapped disclosureFalkland Is.: no separately mapped disclosureNorway: no separately mapped disclosureGreenland: no separately mapped disclosureFr. S. Antarctic Lands: no separately mapped disclosureTimor-Leste: no separately mapped disclosureSouth Africa: no separately mapped disclosureLesotho: no separately mapped disclosureMexico: no separately mapped disclosureUruguay: no separately mapped disclosureBrazil: no separately mapped disclosureBolivia: no separately mapped disclosurePeru: no separately mapped disclosureColombia: no separately mapped disclosurePanama: no separately mapped disclosureCosta Rica: no separately mapped disclosureNicaragua: no separately mapped disclosureHonduras: no separately mapped disclosureEl Salvador: no separately mapped disclosureGuatemala: no separately mapped disclosureBelize: no separately mapped disclosureVenezuela: no separately mapped disclosureGuyana: no separately mapped disclosureSuriname: no separately mapped disclosureFrance: no separately mapped disclosureEcuador: no separately mapped disclosurePuerto Rico: no separately mapped disclosureJamaica: no separately mapped disclosureCuba: no separately mapped disclosureZimbabwe: no separately mapped disclosureBotswana: no separately mapped disclosureNamibia: no separately mapped disclosureSenegal: no separately mapped disclosureMali: no separately mapped disclosureMauritania: no separately mapped disclosureBenin: no separately mapped disclosureNiger: no separately mapped disclosureNigeria: no separately mapped disclosureCameroon: no separately mapped disclosureTogo: no separately mapped disclosureGhana: no separately mapped disclosureCôte d'Ivoire: no separately mapped disclosureGuinea: no separately mapped disclosureGuinea-Bissau: no separately mapped disclosureLiberia: no separately mapped disclosureSierra Leone: no separately mapped disclosureBurkina Faso: no separately mapped disclosureCentral African Rep.: no separately mapped disclosureCongo: no separately mapped disclosureGabon: no separately mapped disclosureEq. Guinea: no separately mapped disclosureZambia: no separately mapped disclosureMalawi: no separately mapped disclosureMozambique: no separately mapped disclosureeSwatini: no separately mapped disclosureAngola: no separately mapped disclosureBurundi: no separately mapped disclosureIsrael: no separately mapped disclosureLebanon: no separately mapped disclosureMadagascar: no separately mapped disclosurePalestine: no separately mapped disclosureGambia: no separately mapped disclosureTunisia: no separately mapped disclosureAlgeria: no separately mapped disclosureJordan: no separately mapped disclosureUnited Arab Emirates: no separately mapped disclosureQatar: no separately mapped disclosureKuwait: no separately mapped disclosureIraq: no separately mapped disclosureOman: no separately mapped disclosureVanuatu: no separately mapped disclosureCambodia: no separately mapped disclosureThailand: no separately mapped disclosureLaos: no separately mapped disclosureMyanmar: no separately mapped disclosureVietnam: no separately mapped disclosureNorth Korea: no separately mapped disclosureSouth Korea: no separately mapped disclosureMongolia: no separately mapped disclosureIndia: no separately mapped disclosureBangladesh: no separately mapped disclosureBhutan: no separately mapped disclosureNepal: no separately mapped disclosurePakistan: no separately mapped disclosureAfghanistan: no separately mapped disclosureTajikistan: no separately mapped disclosureKyrgyzstan: no separately mapped disclosureTurkmenistan: no separately mapped disclosureIran: no separately mapped disclosureSyria: no separately mapped disclosureArmenia: no separately mapped disclosureSweden: no separately mapped disclosureBelarus: no separately mapped disclosureUkraine: no separately mapped disclosurePoland: no separately mapped disclosureAustria: no separately mapped disclosureHungary: no separately mapped disclosureMoldova: no separately mapped disclosureRomania: no separately mapped disclosureLithuania: no separately mapped disclosureLatvia: no separately mapped disclosureEstonia: no separately mapped disclosureGermany: no separately mapped disclosureBulgaria: no separately mapped disclosureGreece: no separately mapped disclosureTurkey: no separately mapped disclosureAlbania: no separately mapped disclosureCroatia: no separately mapped disclosureSwitzerland: no separately mapped disclosureLuxembourg: no separately mapped disclosureBelgium: no separately mapped disclosureNetherlands: no separately mapped disclosurePortugal: no separately mapped disclosureSpain: no separately mapped disclosureIreland: no separately mapped disclosureNew Caledonia: no separately mapped disclosureSolomon Is.: no separately mapped disclosureNew Zealand: no separately mapped disclosureAustralia: no separately mapped disclosureSri Lanka: no separately mapped disclosureChina: no separately mapped disclosureTaiwan: no separately mapped disclosureItaly: no separately mapped disclosureDenmark: no separately mapped disclosureUnited Kingdom: no separately mapped disclosureIceland: no separately mapped disclosureAzerbaijan: no separately mapped disclosureGeorgia: no separately mapped disclosurePhilippines: no separately mapped disclosureMalaysia: no separately mapped disclosureBrunei: no separately mapped disclosureSlovenia: no separately mapped disclosureFinland: no separately mapped disclosureSlovakia: no separately mapped disclosureCzechia: no separately mapped disclosureEritrea: no separately mapped disclosureJapan: no separately mapped disclosureParaguay: no separately mapped disclosureYemen: no separately mapped disclosureSaudi Arabia: no separately mapped disclosureN. Cyprus: no separately mapped disclosureCyprus: no separately mapped disclosureMorocco: no separately mapped disclosureEgypt: no separately mapped disclosureLibya: no separately mapped disclosureEthiopia: no separately mapped disclosureDjibouti: no separately mapped disclosureSomaliland: no separately mapped disclosureUganda: no separately mapped disclosureRwanda: no separately mapped disclosureBosnia and Herz.: no separately mapped disclosureMacedonia: no separately mapped disclosureSerbia: no separately mapped disclosureMontenegro: no separately mapped disclosureKosovo: no separately mapped disclosureTrinidad and Tobago: no separately mapped disclosureS. Sudan: no separately mapped disclosure

    Only separately named countries are coloured. Combined regions and other countries stay in the reported location breakdown.

    Revenue by location

    Q1 26 · USD

    $177KInternational
    Values & sources
    PeriodPeriod endUSDSource
    United States · Q1 262026-03-3120,707,0000001493152-26-022604
    International · Q1 262026-03-31177,0000001493152-26-022604
    United States · Q3 252025-09-3030,312,0000001493152-25-021512
    International · Q3 252025-09-302,943,0000001493152-25-021512
    United States · Q2 252025-06-3032,133,0000001641172-25-023120
    Rest of World · Q2 252025-06-303,278,0000001641172-25-023120
    United States · Q1 252025-03-3130,117,0000001493152-26-022604
    International · Q1 252025-03-312,787,0000001493152-26-022604
    United States · Q4 242024-12-3128,768,000Source unavailable
    Rest of World · Q4 242024-12-312,746,000Source unavailable
    United States · Q3 242024-09-3025,342,0000001493152-25-021512
    International · Q3 242024-09-302,595,0000001493152-25-021512
    United States · Q2 242024-06-3026,276,0000001641172-25-023120
    Rest of World · Q2 242024-06-303,667,0000001641172-25-023120
    United States · Q1 242024-03-3125,133,0000001641172-25-009674
    Rest of World · Q1 242024-03-312,740,0000001641172-25-009674

    Revenue by product

    Q1 26 · USD

    $100KBill And Hold Transactions

    Reported categories are shown independently; no total or percentage is inferred.

    Values & sources
    PeriodPeriod endUSDSource
    Spinal Implant · Q1 262026-03-315,275,0000001493152-26-022604
    Orthobiologics · Q1 262026-03-3115,609,0000001493152-26-022604
    Bill And Hold Transactions · Q1 262026-03-31100,0000001493152-26-022604
    Spinal Implant · Q3 242024-09-3011,358,0000001493152-25-021512
    Orthobiologics · Q3 242024-09-3016,579,0000001493152-25-021512
    Spinal Implant · Q2 242024-06-3013,815,0000001641172-25-023120
    Orthobiologics · Q2 242024-06-3016,128,0000001641172-25-023120
    Spinal Implant · Q1 242024-03-3112,457,0000001641172-25-009674
    Orthobiologics · Q1 242024-03-3115,416,0000001641172-25-009674
    Spinal Implant · Q4 232023-12-3113,036,000Source unavailable
    Orthobiologics · Q4 232023-12-3115,074,000Source unavailable
    Spinal Implant · Q3 232023-09-309,354,0000001493152-24-044764
    Orthobiologics · Q3 232023-09-3015,665,0000001493152-24-044764
    Spinal Implant · Q2 232023-06-305,917,0000001493152-24-030663
    Orthobiologics · Q2 232023-06-3014,315,0000001493152-24-030663
    Spinal Implant · Q1 232023-03-314,391,0000001493152-23-015374
    Other Revenue · Q1 232023-03-311,0000001493152-23-015374
    Orthobiologics · Q1 232023-03-3113,551,0000001493152-23-015374

    Revenue by geography

    Yearly · USD

    Stacked periods reconcile exactly to reported revenue. Periods with missing or overlapping categories are left blank.

    Values & sources
    PeriodPeriod endUSDSource
    United States · FY 252025-12-31122,448,0000001493152-26-013792
    International · FY 252025-12-3111,479,0000001493152-26-013792
    United States · FY 242024-12-31105,519,0000001493152-26-013792
    International · FY 242024-12-3111,748,0000001493152-26-013792
    United States · FY 232023-12-3185,862,0000001493152-25-009391
    Rest of World · FY 232023-12-315,441,0000001493152-25-009391
    United States · FY 222022-12-3157,162,0000001493152-24-012145
    Rest of World · FY 222022-12-31807,0000001493152-24-012145
    United States · FY 212021-12-3154,570,0000001493152-23-006881
    Rest of World · FY 212021-12-31693,0000001493152-23-006881
    United States · FY 202020-12-3152,147,0000001493152-22-006240
    Rest of World · FY 202020-12-311,190,0000001493152-22-006240
    United States · FY 192019-12-3162,377,0000001493152-21-004676
    Rest of World · FY 192019-12-312,305,0000001493152-21-004676
    United States · FY 182018-12-3168,880,0000001493152-20-003410
    Rest of World · FY 182018-12-313,323,0000001493152-20-003410

    Geography growth

    FY 24 to FY 25

    Same fiscal period one year apart.

    Values & sources
    PeriodPeriod endUSDSource
    United States · FY 252025-12-31122,448,0000001493152-26-013792
    International · FY 252025-12-3111,479,0000001493152-26-013792
    United States · FY 242024-12-31105,519,0000001493152-26-013792
    International · FY 242024-12-3111,748,0000001493152-26-013792
    United States · FY 232023-12-3185,862,0000001493152-25-009391
    Rest of World · FY 232023-12-315,441,0000001493152-25-009391
    United States · FY 222022-12-3157,162,0000001493152-24-012145
    Rest of World · FY 222022-12-31807,0000001493152-24-012145
    United States · FY 212021-12-3154,570,0000001493152-23-006881
    Rest of World · FY 212021-12-31693,0000001493152-23-006881
    United States · FY 202020-12-3152,147,0000001493152-22-006240
    Rest of World · FY 202020-12-311,190,0000001493152-22-006240
    United States · FY 192019-12-3162,377,0000001493152-21-004676
    Rest of World · FY 192019-12-312,305,0000001493152-21-004676
    United States · FY 182018-12-3168,880,0000001493152-20-003410
    Rest of World · FY 182018-12-313,323,0000001493152-20-003410

    Revenue around the world

    FY 25 · USD

    Fiji: no separately mapped disclosureTanzania: no separately mapped disclosureW. Sahara: no separately mapped disclosureCanada: no separately mapped disclosureUnited States of America: $122MKazakhstan: no separately mapped disclosureUzbekistan: no separately mapped disclosurePapua New Guinea: no separately mapped disclosureIndonesia: no separately mapped disclosureArgentina: no separately mapped disclosureChile: no separately mapped disclosureDem. Rep. Congo: no separately mapped disclosureSomalia: no separately mapped disclosureKenya: no separately mapped disclosureSudan: no separately mapped disclosureChad: no separately mapped disclosureHaiti: no separately mapped disclosureDominican Rep.: no separately mapped disclosureRussia: no separately mapped disclosureBahamas: no separately mapped disclosureFalkland Is.: no separately mapped disclosureNorway: no separately mapped disclosureGreenland: no separately mapped disclosureFr. S. Antarctic Lands: no separately mapped disclosureTimor-Leste: no separately mapped disclosureSouth Africa: no separately mapped disclosureLesotho: no separately mapped disclosureMexico: no separately mapped disclosureUruguay: no separately mapped disclosureBrazil: no separately mapped disclosureBolivia: no separately mapped disclosurePeru: no separately mapped disclosureColombia: no separately mapped disclosurePanama: no separately mapped disclosureCosta Rica: no separately mapped disclosureNicaragua: no separately mapped disclosureHonduras: no separately mapped disclosureEl Salvador: no separately mapped disclosureGuatemala: no separately mapped disclosureBelize: no separately mapped disclosureVenezuela: no separately mapped disclosureGuyana: no separately mapped disclosureSuriname: no separately mapped disclosureFrance: no separately mapped disclosureEcuador: no separately mapped disclosurePuerto Rico: no separately mapped disclosureJamaica: no separately mapped disclosureCuba: no separately mapped disclosureZimbabwe: no separately mapped disclosureBotswana: no separately mapped disclosureNamibia: no separately mapped disclosureSenegal: no separately mapped disclosureMali: no separately mapped disclosureMauritania: no separately mapped disclosureBenin: no separately mapped disclosureNiger: no separately mapped disclosureNigeria: no separately mapped disclosureCameroon: no separately mapped disclosureTogo: no separately mapped disclosureGhana: no separately mapped disclosureCôte d'Ivoire: no separately mapped disclosureGuinea: no separately mapped disclosureGuinea-Bissau: no separately mapped disclosureLiberia: no separately mapped disclosureSierra Leone: no separately mapped disclosureBurkina Faso: no separately mapped disclosureCentral African Rep.: no separately mapped disclosureCongo: no separately mapped disclosureGabon: no separately mapped disclosureEq. Guinea: no separately mapped disclosureZambia: no separately mapped disclosureMalawi: no separately mapped disclosureMozambique: no separately mapped disclosureeSwatini: no separately mapped disclosureAngola: no separately mapped disclosureBurundi: no separately mapped disclosureIsrael: no separately mapped disclosureLebanon: no separately mapped disclosureMadagascar: no separately mapped disclosurePalestine: no separately mapped disclosureGambia: no separately mapped disclosureTunisia: no separately mapped disclosureAlgeria: no separately mapped disclosureJordan: no separately mapped disclosureUnited Arab Emirates: no separately mapped disclosureQatar: no separately mapped disclosureKuwait: no separately mapped disclosureIraq: no separately mapped disclosureOman: no separately mapped disclosureVanuatu: no separately mapped disclosureCambodia: no separately mapped disclosureThailand: no separately mapped disclosureLaos: no separately mapped disclosureMyanmar: no separately mapped disclosureVietnam: no separately mapped disclosureNorth Korea: no separately mapped disclosureSouth Korea: no separately mapped disclosureMongolia: no separately mapped disclosureIndia: no separately mapped disclosureBangladesh: no separately mapped disclosureBhutan: no separately mapped disclosureNepal: no separately mapped disclosurePakistan: no separately mapped disclosureAfghanistan: no separately mapped disclosureTajikistan: no separately mapped disclosureKyrgyzstan: no separately mapped disclosureTurkmenistan: no separately mapped disclosureIran: no separately mapped disclosureSyria: no separately mapped disclosureArmenia: no separately mapped disclosureSweden: no separately mapped disclosureBelarus: no separately mapped disclosureUkraine: no separately mapped disclosurePoland: no separately mapped disclosureAustria: no separately mapped disclosureHungary: no separately mapped disclosureMoldova: no separately mapped disclosureRomania: no separately mapped disclosureLithuania: no separately mapped disclosureLatvia: no separately mapped disclosureEstonia: no separately mapped disclosureGermany: no separately mapped disclosureBulgaria: no separately mapped disclosureGreece: no separately mapped disclosureTurkey: no separately mapped disclosureAlbania: no separately mapped disclosureCroatia: no separately mapped disclosureSwitzerland: no separately mapped disclosureLuxembourg: no separately mapped disclosureBelgium: no separately mapped disclosureNetherlands: no separately mapped disclosurePortugal: no separately mapped disclosureSpain: no separately mapped disclosureIreland: no separately mapped disclosureNew Caledonia: no separately mapped disclosureSolomon Is.: no separately mapped disclosureNew Zealand: no separately mapped disclosureAustralia: no separately mapped disclosureSri Lanka: no separately mapped disclosureChina: no separately mapped disclosureTaiwan: no separately mapped disclosureItaly: no separately mapped disclosureDenmark: no separately mapped disclosureUnited Kingdom: no separately mapped disclosureIceland: no separately mapped disclosureAzerbaijan: no separately mapped disclosureGeorgia: no separately mapped disclosurePhilippines: no separately mapped disclosureMalaysia: no separately mapped disclosureBrunei: no separately mapped disclosureSlovenia: no separately mapped disclosureFinland: no separately mapped disclosureSlovakia: no separately mapped disclosureCzechia: no separately mapped disclosureEritrea: no separately mapped disclosureJapan: no separately mapped disclosureParaguay: no separately mapped disclosureYemen: no separately mapped disclosureSaudi Arabia: no separately mapped disclosureN. Cyprus: no separately mapped disclosureCyprus: no separately mapped disclosureMorocco: no separately mapped disclosureEgypt: no separately mapped disclosureLibya: no separately mapped disclosureEthiopia: no separately mapped disclosureDjibouti: no separately mapped disclosureSomaliland: no separately mapped disclosureUganda: no separately mapped disclosureRwanda: no separately mapped disclosureBosnia and Herz.: no separately mapped disclosureMacedonia: no separately mapped disclosureSerbia: no separately mapped disclosureMontenegro: no separately mapped disclosureKosovo: no separately mapped disclosureTrinidad and Tobago: no separately mapped disclosureS. Sudan: no separately mapped disclosure

    Only separately named countries are coloured. Combined regions and other countries stay in the reported location breakdown.

    Revenue by location

    FY 25 · USD

    $11.5MInternational
    Values & sources
    PeriodPeriod endUSDSource
    United States · FY 252025-12-31122,448,0000001493152-26-013792
    International · FY 252025-12-3111,479,0000001493152-26-013792
    United States · FY 242024-12-31105,519,0000001493152-26-013792
    International · FY 242024-12-3111,748,0000001493152-26-013792
    United States · FY 232023-12-3185,862,0000001493152-25-009391
    Rest of World · FY 232023-12-315,441,0000001493152-25-009391
    United States · FY 222022-12-3157,162,0000001493152-24-012145
    Rest of World · FY 222022-12-31807,0000001493152-24-012145
    United States · FY 212021-12-3154,570,0000001493152-23-006881
    Rest of World · FY 212021-12-31693,0000001493152-23-006881
    United States · FY 202020-12-3152,147,0000001493152-22-006240
    Rest of World · FY 202020-12-311,190,0000001493152-22-006240
    United States · FY 192019-12-3162,377,0000001493152-21-004676
    Rest of World · FY 192019-12-312,305,0000001493152-21-004676
    United States · FY 182018-12-3168,880,0000001493152-20-003410
    Rest of World · FY 182018-12-313,323,0000001493152-20-003410

    Revenue by product

    Yearly · USD

    Stacked periods reconcile exactly to reported revenue. Periods with missing or overlapping categories are left blank.

    Values & sources
    PeriodPeriod endUSDSource
    Spinal Implant · FY 232023-12-3132,698,0000001493152-25-009391
    Orthobiologics · FY 232023-12-3158,605,0000001493152-25-009391
    Spinal Implant · FY 222022-12-3110,815,0000001493152-23-006881
    Other Revenue · FY 222022-12-3111,0000001493152-23-006881
    Orthobiologics · FY 222022-12-3147,143,0000001493152-23-006881
    Spinal Implant · FY 212021-12-3112,887,0000001493152-23-006881
    Other Revenue · FY 212021-12-31117,0000001493152-23-006881
    Orthobiologics · FY 212021-12-3142,259,0000001493152-23-006881
    Spinal Implant · FY 202020-12-3113,880,0000001493152-22-006240
    Other Revenue · FY 202020-12-31149,0000001493152-22-006240
    Orthobiologics · FY 202020-12-3139,308,0000001493152-22-006240
    Spinal Implant · FY 192019-12-3117,872,0000001493152-21-004676
    Other Revenue · FY 192019-12-31147,0000001493152-21-004676
    Orthobiologics · FY 192019-12-3146,663,0000001493152-21-004676
    Spinal Implant · FY 182018-12-3122,830,0000001493152-20-003410
    Other Revenue · FY 182018-12-31389,0000001493152-20-003410
    Orthobiologics · FY 182018-12-3148,984,0000001493152-20-003410

    Product growth

    FY 22 to FY 23

    Same fiscal period one year apart.

    Values & sources
    PeriodPeriod endUSDSource
    Spinal Implant · FY 232023-12-3132,698,0000001493152-25-009391
    Orthobiologics · FY 232023-12-3158,605,0000001493152-25-009391
    Spinal Implant · FY 222022-12-3110,815,0000001493152-23-006881
    Other Revenue · FY 222022-12-3111,0000001493152-23-006881
    Orthobiologics · FY 222022-12-3147,143,0000001493152-23-006881
    Spinal Implant · FY 212021-12-3112,887,0000001493152-23-006881
    Other Revenue · FY 212021-12-31117,0000001493152-23-006881
    Orthobiologics · FY 212021-12-3142,259,0000001493152-23-006881
    Spinal Implant · FY 202020-12-3113,880,0000001493152-22-006240
    Other Revenue · FY 202020-12-31149,0000001493152-22-006240
    Orthobiologics · FY 202020-12-3139,308,0000001493152-22-006240
    Spinal Implant · FY 192019-12-3117,872,0000001493152-21-004676
    Other Revenue · FY 192019-12-31147,0000001493152-21-004676
    Orthobiologics · FY 192019-12-3146,663,0000001493152-21-004676
    Spinal Implant · FY 182018-12-3122,830,0000001493152-20-003410
    Other Revenue · FY 182018-12-31389,0000001493152-20-003410
    Orthobiologics · FY 182018-12-3148,984,0000001493152-20-003410

    Income statement

    From revenue to profit.

    Income reporting period

    Revenue

    Quarterly · USD

    $23MQ2 26
    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Revenue2026-06-3023,031,000Disclosure Q2 26 · Revenue
    Q1 26 · Revenue2026-03-3120,884,000Source unavailable
    Q4 25 · Revenue2025-12-3132,357,000Source unavailable
    Q3 25 · Revenue2025-09-3033,255,000Source unavailable
    Q2 25 · Revenue2025-06-3035,411,000Source unavailable
    Q1 25 · Revenue2025-03-3132,904,000Source unavailable
    Q4 24 · Revenue2024-12-3131,513,000Source unavailable
    Q3 24 · Revenue2024-09-3027,937,000Source unavailable

    Revenue and profit

    Quarterly · USD

    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Net income2026-06-30-9,400,000Disclosure Q2 26 · Net income
    Q2 26 · Gross profit2026-06-3013,330,000Disclosure Q2 26 · Gross profit
    Q2 26 · Revenue2026-06-3023,031,000Disclosure Q2 26 · Revenue
    Q1 26 · Net income2026-03-31-3,089,000Source unavailable
    Q1 26 · Gross profit2026-03-3111,971,000Source unavailable
    Q1 26 · Revenue2026-03-3120,884,000Source unavailable
    Q4 25 · Net income2025-12-3157,000Source unavailable
    Q4 25 · Gross profit2025-12-3117,754,000Source unavailable
    Q4 25 · Revenue2025-12-3132,357,000Source unavailable
    Q3 25 · Net income2025-09-301,308,000Source unavailable
    Q3 25 · Gross profit2025-09-3021,992,000Source unavailable
    Q3 25 · Revenue2025-09-3033,255,000Source unavailable
    Q2 25 · Net income2025-06-303,550,000Source unavailable
    Q2 25 · Gross profit2025-06-3024,284,000Source unavailable
    Q2 25 · Revenue2025-06-3035,411,000Source unavailable
    Q1 25 · Net income2025-03-3158,000Source unavailable
    Q1 25 · Gross profit2025-03-3120,243,000Source unavailable
    Q1 25 · Revenue2025-03-3132,904,000Source unavailable
    Q4 24 · Net income2024-12-31-3,165,000Source unavailable
    Q4 24 · Gross profit2024-12-3116,024,000Source unavailable
    Q4 24 · Revenue2024-12-3131,513,000Source unavailable
    Q3 24 · Net income2024-09-30-5,024,000Source unavailable
    Q3 24 · Gross profit2024-09-3016,307,000Source unavailable
    Q3 24 · Revenue2024-09-3027,937,000Source unavailable

    From revenue to net income

    Q2 26 · USD

    $-9.4MNet income

    Hatched marks are outflows or deductions. Reconciliation differences are calculated, not separately reported categories.

    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Net income2026-06-30-9,400,000Disclosure Q2 26 · Net income
    Q2 26 · Tax / other2026-06-30-231,000Disclosure Q2 26 · Tax / other
    Q2 26 · Operating income2026-06-30-9,169,000Disclosure Q2 26 · Operating income
    Q2 26 · Operating expenses2026-06-30-22,499,000Disclosure Q2 26 · Operating expenses
    Q2 26 · Gross profit2026-06-3013,330,000Disclosure Q2 26 · Gross profit
    Q2 26 · Cost of revenue2026-06-30-9,701,000Disclosure Q2 26 · Cost of revenue
    Q2 26 · Revenue2026-06-3023,031,000Disclosure Q2 26 · Revenue

    Operating leverage

    Year-over-year change · percent

    Growth compares the same fiscal quarter one year earlier. Exact reported inputs are below.

    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Total Operating Expenses2026-06-3022,499,000Disclosure Q2 26 · Total Operating Expenses
    Q2 26 · Total Revenue2026-06-3023,031,000Disclosure Q2 26 · Total Revenue
    Q1 26 · Total Operating Expenses2026-03-3114,894,000Source unavailable
    Q1 26 · Total Revenue2026-03-3120,884,000Source unavailable
    Q4 25 · Total Operating Expenses2025-12-3118,698,000Source unavailable
    Q4 25 · Total Revenue2025-12-3132,357,000Source unavailable
    Q3 25 · Total Operating Expenses2025-09-3019,451,000Source unavailable
    Q3 25 · Total Revenue2025-09-3033,255,000Source unavailable
    Q2 25 · Total Operating Expenses2025-06-3019,660,000Source unavailable
    Q2 25 · Total Revenue2025-06-3035,411,000Source unavailable
    Q1 25 · Total Operating Expenses2025-03-3119,180,000Source unavailable
    Q1 25 · Total Revenue2025-03-3132,904,000Source unavailable
    Q4 24 · Total Operating Expenses2024-12-3117,906,000Source unavailable
    Q4 24 · Total Revenue2024-12-3131,513,000Source unavailable
    Q3 24 · Total Operating Expenses2024-09-3020,084,000Source unavailable
    Q3 24 · Total Revenue2024-09-3027,937,000Source unavailable

    Revenue

    Yearly · USD

    $134MFY 25
    Values & sources
    PeriodPeriod endUSDSource
    FY 25 · Revenue2025-12-31133,927,000Source unavailable
    FY 24 · Revenue2024-12-31117,267,000Source unavailable
    FY 23 · Revenue2023-12-3191,303,000Source unavailable
    FY 22 · Revenue2022-12-3157,969,000Source unavailable
    FY 21 · Revenue2021-12-3155,263,000Source unavailable
    FY 20 · Revenue2020-12-3153,337,000Source unavailable
    FY 19 · Revenue2019-12-3164,682,000Source unavailable

    Revenue and profit

    Yearly · USD

    Values & sources
    PeriodPeriod endUSDSource
    FY 25 · Net income2025-12-314,973,000Source unavailable
    FY 25 · Gross profit2025-12-3184,273,000Source unavailable
    FY 25 · Revenue2025-12-31133,927,000Source unavailable
    FY 24 · Net income2024-12-31-16,449,000Source unavailable
    FY 24 · Gross profit2024-12-3168,216,000Source unavailable
    FY 24 · Revenue2024-12-31117,267,000Source unavailable
    FY 23 · Net income2023-12-31660,000Source unavailable
    FY 23 · Gross profit2023-12-3155,467,000Source unavailable
    FY 23 · Revenue2023-12-3191,303,000Source unavailable
    FY 22 · Net income2022-12-31-8,485,000Source unavailable
    FY 22 · Gross profit2022-12-3132,137,000Source unavailable
    FY 22 · Revenue2022-12-3157,969,000Source unavailable
    FY 21 · Net income2021-12-31-4,849,000Source unavailable
    FY 21 · Gross profit2021-12-3132,490,000Source unavailable
    FY 21 · Revenue2021-12-3155,263,000Source unavailable
    FY 20 · Net income2020-12-31-7,023,000Source unavailable
    FY 20 · Gross profit2020-12-3134,392,000Source unavailable
    FY 20 · Revenue2020-12-3153,337,000Source unavailable
    FY 19 · Net income2019-12-31-8,221,000Source unavailable
    FY 19 · Gross profit2019-12-3142,516,000Source unavailable
    FY 19 · Revenue2019-12-3164,682,000Source unavailable

    From revenue to net income

    FY 25 · USD

    $4.97MNet income

    Hatched marks are outflows or deductions. Reconciliation differences are calculated, not separately reported categories.

    Values & sources
    PeriodPeriod endUSDSource
    FY 25 · Net income2025-12-314,973,000Source unavailable
    FY 25 · Tax / other2025-12-31-2,028,000Source unavailable
    FY 25 · Pretax income2025-12-317,001,000Source unavailable
    FY 25 · Other, net2025-12-31-283,000Source unavailable
    FY 25 · Operating income2025-12-317,284,000Source unavailable
    FY 25 · Operating expenses2025-12-31-76,989,000Source unavailable
    FY 25 · Gross profit2025-12-3184,273,000Source unavailable
    FY 25 · Cost of revenue2025-12-31-49,654,000Source unavailable
    FY 25 · Revenue2025-12-31133,927,000Source unavailable

    Cash flow

    Cash generated and cash spent.

    Cash flow reporting period

    Free cash flow

    Quarterly · USD

    Operating cash flow plus signed capital expenditures; both inputs must be available for the same period.

    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Free cash flow2026-06-30—Disclosure Q2 26 · Free cash flow
    Q1 26 · Free cash flow2026-03-31-2,308,000Source unavailable
    Q4 25 · Free cash flow2025-12-314,985,000Source unavailable
    Q3 25 · Free cash flow2025-09-304,182,000Source unavailable
    Q2 25 · Free cash flow2025-06-30910,000Source unavailable
    Q1 25 · Free cash flow2025-03-3187,000Source unavailable
    Q4 24 · Free cash flow2024-12-31-7,000Source unavailable
    Q3 24 · Free cash flow2024-09-30-3,822,000Source unavailable

    Free cash flow

    Yearly · USD

    $10.2MFY 25

    Operating cash flow plus signed capital expenditures; both inputs must be available for the same period.

    Values & sources
    PeriodPeriod endUSDSource
    FY 25 · Free cash flow2025-12-3110,164,000Source unavailable
    FY 24 · Free cash flow2024-12-31-16,009,000Source unavailable
    FY 23 · Free cash flow2023-12-31-10,971,000Source unavailable
    FY 22 · Free cash flow2022-12-31-7,105,000Source unavailable
    FY 21 · Free cash flow2021-12-31-1,676,000Source unavailable
    FY 20 · Free cash flow2020-12-31-2,276,000Source unavailable
    FY 19 · Free cash flow2019-12-31-1,292,000Source unavailable

    Balance sheet

    What the company owns and what it owes.

    Balance sheet reporting period

    Cash and short-term investments

    Quarterly · USD

    Both components must be reported for the period.

    Values & sources
    PeriodPeriod endUSDSource
    Q2 26 · Short-term investments2026-06-30—Disclosure Q2 26 · Short-term investments
    Q2 26 · Cash & equivalents2026-06-309,870,000Disclosure Q2 26 · Cash & equivalents
    Q1 26 · Short-term investments2026-03-31—Source unavailable
    Q1 26 · Cash & equivalents2026-03-31—Source unavailable
    Q4 25 · Short-term investments2025-12-31—Source unavailable
    Q4 25 · Cash & equivalents2025-12-31—Source unavailable
    Q3 25 · Short-term investments2025-09-30—Source unavailable
    Q3 25 · Cash & equivalents2025-09-30—Source unavailable
    Q2 25 · Short-term investments2025-06-30—Source unavailable
    Q2 25 · Cash & equivalents2025-06-30—Source unavailable
    Q1 25 · Short-term investments2025-03-31—Source unavailable
    Q1 25 · Cash & equivalents2025-03-31—Source unavailable
    Q4 24 · Short-term investments2024-12-31—Source unavailable
    Q4 24 · Cash & equivalents2024-12-31—Source unavailable
    Q3 24 · Short-term investments2024-09-30—Source unavailable
    Q3 24 · Cash & equivalents2024-09-30—Source unavailable

    Total assets

    Yearly · USD

    $94.1MFY 25
    Values & sources
    PeriodPeriod endUSDSource
    FY 25 · Assets2025-12-3194,145,000Source unavailable
    FY 24 · Assets2024-12-3193,837,000Source unavailable
    FY 23 · Assets2023-12-3192,612,000Source unavailable
    FY 22 · Assets2022-12-3160,229,000Source unavailable
    FY 21 · Assets2021-12-3154,692,000Source unavailable
    FY 20 · Assets2020-12-3141,466,000Source unavailable
    FY 19 · Assets2019-12-3143,155,000Source unavailable

    Financial statements

    Every published field, with exact amounts and disclosure sources.

    View full financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue23,031,000USD20,884,000USD32,357,000USD33,255,000USD35,411,000USD32,904,000USD31,513,000USD27,937,000USD
    Cost Of Revenue9,701,000USD8,913,000USD14,603,000USD11,263,000USD11,127,000USD12,661,000USD15,489,000USD11,630,000USD
    Gross Profit13,330,000USD11,971,000USD17,754,000USD21,992,000USD24,284,000USD20,243,000USD16,024,000USD16,307,000USD
    Research Development695,000USD435,000USD459,000USD634,000USD566,000USD443,000USD522,000USD701,000USD
    Total Operating Expenses22,499,000USD14,894,000USD18,698,000USD19,451,000USD19,660,000USD19,180,000USD17,906,000USD20,084,000USD
    Operating Income-9,169,000USD-2,923,000USD-944,000USD2,541,000USD4,624,000USD1,063,000USD-1,882,000USD-3,777,000USD
    Income Tax Expense9,340,000USD27,000USD1,541,000USD257,000USD255,000USD-25,000USD21,000USD62,000USD
    Net Income-9,400,000USD-3,089,000USD57,000USD1,308,000USD3,550,000USD58,000USD-3,165,000USD-5,024,000USD
    Selling General Administrative—6,273,000USD7,293,000USD7,071,000USD7,478,000USD7,533,000USD5,700,000USD7,493,000USD
    Selling And Marketing Expenses—8,186,000USD10,946,000USD11,746,000USD11,616,000USD11,204,000USD11,684,000USD11,890,000USD
    Interest Income—219,000USD———0USD0USD0USD
    Interest Expense—599,000USD718,000USD904,000USD1,004,000USD1,045,000USD1,134,000USD1,199,000USD
    Net Interest Income—-380,000USD-624,000USD-904,000USD-1,004,000USD-1,045,000USD-1,134,000USD-1,199,000USD
    Income Before Tax—-3,062,000USD1,598,000USD1,565,000USD3,805,000USD33,000USD-3,144,000USD-4,962,000USD
    Tax Provision—27,000USD1,541,000USD257,000USD255,000USD-25,000USD21,000USD62,000USD
    Net Income From Continuing Ops—-3,089,000USD57,000USD1,308,000USD3,550,000USD58,000USD-3,165,000USD-5,024,000USD
    Ebit—-2,923,000USD2,316,000USD2,469,000USD4,809,000USD1,078,000USD-2,010,000USD-3,763,000USD
    Ebitda—-2,389,000USD4,135,000USD3,630,000USD5,978,000USD2,152,000USD-862,000USD-2,690,000USD
    Depreciation And Amortization—534,000USD1,819,000USD1,161,000USD1,169,000USD1,074,000USD1,148,000USD1,073,000USD
    Reconciled Depreciation—534,000USD1,819,000USD1,161,000USD1,169,000USD1,074,000USD1,148,000USD1,073,000USD
    Total Other Income Expense Net—-139,000USD2,542,000USD-976,000USD-819,000USD-1,030,000USD-1,262,000USD-1,185,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue133,927,000USD117,267,000USD91,303,000USD57,969,000USD55,263,000USD53,337,000USD64,682,000USD
    Cost Of Revenue49,654,000USD49,051,000USD35,836,000USD25,832,000USD22,773,000USD18,945,000USD22,166,000USD
    Gross Profit84,273,000USD68,216,000USD55,467,000USD32,137,000USD32,490,000USD34,392,000USD42,516,000USD
    Research Development2,102,000USD2,385,000USD1,336,000USD915,000USD870,000USD657,000USD932,000USD
    Selling General Administrative29,375,000USD28,691,000USD25,850,000USD15,462,000USD14,449,000USD13,503,000USD17,936,000USD
    Selling And Marketing Expenses45,512,000USD49,214,000USD38,439,000USD22,515,000USD21,025,000USD20,983,000USD25,843,000USD
    Total Operating Expenses76,989,000USD80,290,000USD65,625,000USD38,892,000USD36,344,000USD35,143,000USD44,769,000USD
    Operating Income7,284,000USD-12,074,000USD-10,158,000USD-6,755,000USD-3,854,000USD-751,000USD-2,354,000USD
    Interest Income94,000USD0USD164,000USD31,000USD0USD—5,769,000USD
    Interest Expense3,671,000USD4,160,000USD2,938,000USD1,692,000USD995,000USD5,976,000USD5,772,000USD
    Net Interest Income-3,577,000USD-4,160,000USD-2,451,000USD-1,661,000USD-995,000USD-5,976,000USD-5,772,000USD
    Income Before Tax7,001,000USD-16,262,000USD-1,037,000USD-8,416,000USD-4,849,000USD-6,727,000USD-8,123,000USD
    Income Tax Expense2,028,000USD187,000USD-1,697,000USD69,000USD995,000USD296,000USD98,000USD
    Tax Provision2,028,000USD187,000USD-2,253,000USD69,000USD322,000USD296,000USD98,000USD
    Net Income4,973,000USD-16,449,000USD660,000USD-8,485,000USD-4,849,000USD-7,023,000USD-8,221,000USD
    Net Income From Continuing Ops4,973,000USD-16,449,000USD2,754,000USD-8,485,000USD-4,849,000USD-7,023,000USD-8,221,000USD
    Ebit10,672,000USD-12,102,000USD1,901,000USD-6,724,000USD-3,854,000USD-751,000USD-2,351,000USD
    Ebitda15,895,000USD-7,878,000USD5,075,000USD-5,428,000USD-2,513,000USD1,328,000USD850,000USD
    Depreciation And Amortization5,223,000USD4,224,000USD3,174,000USD1,296,000USD1,341,000USD2,079,000USD3,201,000USD
    Reconciled Depreciation5,223,000USD4,224,000USD2,478,000USD1,292,000USD1,332,000USD2,079,000USD3,143,000USD
    Total Other Income Expense Net-283,000USD-4,188,000USD9,121,000USD-1,661,000USD-995,000USD-5,976,000USD-5,870,000USD
    Non Operating Income Net Other———31,000USD——-98,000USD
    Net Income Applicable To Common Shares———-8,485,000USD-4,849,000USD-7,023,000USD-8,221,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets79,667,000USD78,000,000USD94,145,000USD106,321,000USD103,479,000USD95,833,000USD93,837,000USD98,882,000USD
    Cash And Equivalents9,870,000USD———————
    Total Current Assets64,777,000USD62,621,000USD78,245,000USD78,330,000USD75,589,000USD69,144,000USD67,116,000USD71,410,000USD
    Total Liabilities39,652,000USD———————
    Total Current Liabilities29,963,000USD18,773,000USD29,484,000USD35,503,000USD30,600,000USD29,581,000USD28,581,000USD33,669,000USD
    Short Long Term Debt3,720,000USD4,161,000USD14,357,000USD11,308,000USD12,006,000USD11,261,000USD12,120,000USD15,637,000USD
    Net Receivables19,416,000USD17,179,000USD17,803,000USD25,517,000USD26,951,000USD23,476,000USD20,660,000USD20,545,000USD
    Inventory33,287,000USD31,881,000USD30,263,000USD40,714,000USD40,135,000USD38,812,000USD38,634,000USD41,886,000USD
    Property Plant Equipment Net5,542,000USD8,899,000USD9,394,000USD13,628,000USD13,081,000USD11,462,000USD10,960,000USD11,279,000USD
    Goodwill6,074,000USD———————
    Intangible Assets—275,000USD299,000USD7,060,000USD7,492,000USD7,924,000USD8,356,000USD8,788,000USD
    Other Current Assets—1,404,000USD13,126,000USD1,699,000USD1,580,000USD1,824,000USD1,623,000USD2,383,000USD
    Total Liab—29,401,000USD43,192,000USD55,938,000USD54,977,000USD51,956,000USD50,874,000USD53,157,000USD
    Total Stockholder Equity—48,599,000USD50,953,000USD50,383,000USD48,502,000USD43,877,000USD42,963,000USD45,725,000USD
    Other Current Liab—8,475,000USD10,626,000USD16,535,000USD10,626,000USD10,492,000USD7,771,000USD8,871,000USD
    Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Retained Earnings—-257,575,000USD-254,486,000USD-254,543,000USD-255,851,000USD-259,401,000USD-259,459,000USD-256,295,000USD
    Good Will—6,074,000USD6,074,000USD7,302,000USD7,302,000USD7,302,000USD7,302,000USD7,302,000USD
    Other Assets—1USD——————
    Cash—12,157,000USD17,053,000USD10,400,000USD6,923,000USD5,032,000USD6,199,000USD6,596,000USD
    Cash And Short Term Investments—12,157,000USD17,053,000USD10,400,000USD6,923,000USD5,032,000USD6,199,000USD6,596,000USD
    Net Debt—3,279,000USD11,664,000USD22,087,000USD30,151,000USD29,263,000USD28,944,000USD29,354,000USD
    Short Term Debt—4,813,000USD15,014,000USD12,112,000USD12,751,000USD11,968,000USD12,892,000USD16,500,000USD
    Short Long Term Debt Total—15,436,000USD28,717,000USD32,487,000USD37,074,000USD34,295,000USD35,143,000USD35,950,000USD
    Long Term Debt—8,095,000USD11,026,000USD17,404,000USD22,278,000USD22,167,000USD22,038,000USD19,138,000USD
    Accounts Payable—5,485,000USD3,844,000USD6,856,000USD7,223,000USD7,121,000USD7,918,000USD8,298,000USD
    Property Plant Equipment Gross—31,345,000USD31,601,000USD35,488,000USD34,255,000USD31,962,000USD30,797,000USD32,272,000USD
    Accumulated Other Comprehensive Income—-1,000USD—139,000USD152,000USD-209,000USD-316,000USD54,000USD
    Common Stock Shares Outstanding—150,462,888shares150,462,888shares148,574,242shares148,574,242shares143,335,114shares138,977,615shares135,100,233shares
    Non Current Assets Total—15,378,999USD15,900,000USD27,991,000USD27,890,000USD26,689,000USD26,721,000USD27,472,000USD
    Non Current Liabilities Total—10,628,000USD13,708,000USD20,435,000USD24,377,000USD22,375,000USD22,293,000USD19,488,000USD
    Non Currrent Assets Other—130,999USD133,000USD1,000USD15,000USD1,000USD103,000USD103,000USD
    Net Working Capital—43,848,000USD48,761,000USD42,827,000USD44,989,000USD39,563,000USD38,535,000USD37,741,000USD
    Unclassified Current Liabilities—-4,161,000USD-14,357,000USD-11,308,000USD-12,006,000USD-11,261,000USD-12,120,000USD-15,637,000USD
    Unclassified Non Current Liabilities—2,533,000USD2,682,000USD3,031,000USD2,099,000USD———
    Unclassified Equity—306,175,000USD305,439,000USD304,787,000USD304,201,000USD303,487,000USD302,738,000USD301,966,000USD
    Current Deferred Revenue———————-863,000USD
    Non Current Liabilities Other———————38,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets94,145,000USD93,837,000USD92,612,000USD60,229,000USD54,692,000USD41,466,000USD43,155,000USD
    Intangible Assets299,000USD8,356,000USD10,085,000USD344,000USD400,000USD457,000USD515,000USD
    Other Current Assets13,126,000USD1,623,000USD1,538,000USD882,000USD988,000USD736,000USD784,000USD
    Total Liab43,192,000USD50,874,000USD41,263,000USD26,058,000USD23,809,000USD26,952,000USD87,360,000USD
    Total Stockholder Equity50,953,000USD42,963,000USD51,349,000USD34,171,000USD30,883,000USD14,514,000USD-44,205,000USD
    Other Current Liab10,626,000USD7,771,000USD10,419,000USD5,496,000USD4,349,000USD6,120,000USD-563,000USD
    Capital Stock0USD0USD0USD0USD0USD0USD0USD
    Retained Earnings-254,486,000USD-259,459,000USD-243,010,000USD-243,670,000USD-235,185,000USD-230,336,000USD-223,266,000USD
    Good Will6,074,000USD7,302,000USD7,302,000USD3,205,000USD3,205,000USD3,205,000USD3,205,000USD
    Cash17,053,000USD6,199,000USD5,715,000USD20,298,000USD18,243,000USD2,341,000USD5,237,000USD
    Cash And Short Term Investments17,053,000USD6,199,000USD5,715,000USD20,298,000USD18,243,000USD2,341,000USD5,237,000USD
    Total Current Assets78,245,000USD67,116,000USD64,869,000USD49,318,000USD44,330,000USD31,365,000USD32,246,000USD
    Total Current Liabilities29,484,000USD28,581,000USD22,990,000USD15,218,000USD11,077,000USD25,649,000USD9,390,000USD
    Net Debt11,664,000USD28,944,000USD17,844,000USD-3,226,000USD-1,398,000USD16,202,000USD73,303,000USD
    Short Term Debt15,014,000USD12,892,000USD5,517,000USD6,232,000USD4,113,000USD17,240,000USD1,140,000USD
    Short Long Term Debt14,357,000USD12,120,000USD4,622,000USD5,712,000USD3,620,000USD16,797,000USD—
    Short Long Term Debt Total28,717,000USD35,143,000USD23,559,000USD17,072,000USD16,845,000USD18,543,000USD78,540,000USD
    Long Term Debt11,026,000USD22,038,000USD17,167,000USD9,687,000USD11,787,000USD—76,244,000USD
    Net Receivables17,803,000USD20,660,000USD20,731,000USD10,853,000USD7,154,000USD6,880,000USD10,124,000USD
    Inventory30,263,000USD38,634,000USD36,885,000USD17,285,000USD17,945,000USD21,408,000USD16,101,000USD
    Accounts Payable3,844,000USD7,918,000USD7,054,000USD3,490,000USD2,615,000USD2,289,000USD2,188,000USD
    Property Plant Equipment Net9,394,000USD10,960,000USD10,215,000USD7,165,000USD6,470,000USD6,037,000USD6,795,000USD
    Property Plant Equipment Gross31,601,000USD30,797,000USD29,895,000USD7,165,000USD6,470,000USD4,347,000USD6,795,000USD
    Common Stock Shares Outstanding150,042,556shares133,665,075shares126,793,318shares94,085,197shares85,456,175shares28,499,847shares13,163,931shares
    Non Current Assets Total15,900,000USD26,721,000USD27,743,000USD10,911,000USD10,362,000USD10,101,000USD10,909,000USD
    Non Current Liabilities Total13,708,000USD22,293,000USD18,273,000USD10,840,000USD12,732,000USD1,303,000USD77,970,000USD
    Non Currrent Assets Other133,000USD103,000USD141,000USD197,000USD287,000USD402,000USD394,000USD
    Net Working Capital48,761,000USD38,535,000USD41,879,000USD34,100,000USD33,253,000USD5,716,000USD22,856,000USD
    Unclassified Current Liabilities-14,357,000USD-12,120,000USD-4,622,000USD-5,712,000USD-3,620,000USD-16,797,000USD—
    Unclassified Non Current Liabilities2,682,000USD—1,106,000USD————
    Unclassified Equity305,439,000USD302,738,000USD294,330,000USD277,841,000USD266,068,000USD244,850,000USD179,061,000USD
    Accumulated Other Comprehensive Income—-316,000USD29,000USD0USD0USD0USD0USD
    Other Assets——1USD197,000USD287,000USD2,092,000USD394,000USD
    Non Current Liabilities Other———1,153,000USD—1,303,000USD1,726,000USD
    Net Tangible Assets———30,622,000USD27,278,000USD10,852,000USD-47,925,000USD
    Unclassified Non Current Assets—————-2,092,000USD—
    Current Deferred Revenue——————6,625,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Depreciation508,000USD534,000USD1,819,000USD1,161,000USD1,169,000USD1,074,000USD1,148,000USD1,073,000USD
    Stock Based Compensation1,621,000USD746,000USD727,000USD641,000USD766,000USD758,000USD840,000USD1,139,000USD
    Capital Expenditures-441,000USD-194,000USD-395,000USD-430,000USD-366,000USD-1,191,000USD-672,000USD-2,104,000USD
    Financing Cash Flow-2,717,000USD———————
    Change In Cash-7,111,000USD-5,171,000USD6,687,000USD3,604,000USD1,602,000USD-786,000USD-865,000USD1,608,000USD
    End Cash Flow10,217,000USD———————
    Net Income—-3,089,000USD57,000USD1,308,000USD3,550,000USD58,000USD-3,165,000USD-5,023,000USD
    Other Non Cash Items—1,219,000USD151,000USD1,823,000USD264,000USD907,000USD350,000USD568,000USD
    Change To Account Receivables—444,000USD5,048,000USD1,234,000USD-3,759,000USD-3,114,000USD-627,000USD560,000USD
    Change To Inventory—-1,611,000USD790,000USD-1,440,000USD-814,000USD-535,000USD3,163,000USD-1,527,000USD
    Change In Working Capital—-1,524,000USD2,626,000USD320,000USD-4,473,000USD-1,519,000USD1,492,000USD525,000USD
    Total Cash From Operating Activities—-2,114,000USD5,380,000USD4,612,000USD1,276,000USD1,278,000USD665,000USD-1,718,000USD
    Free Cash Flow—-2,308,000USD4,985,000USD4,182,000USD910,000USD87,000USD-7,000USD-3,822,000USD
    Total Cashflows From Investing Activities—10,220,000USD4,680,000USD4,679,000USD-317,000USD-1,143,000USD-567,000USD-2,009,000USD
    Net Borrowings—-13,265,000USD-3,467,000USD-5,716,000USD729,000USD-876,000USD-135,000USD971,000USD
    Total Cash From Financing Activities—-13,275,000USD-3,542,000USD-5,771,000USD662,000USD-919,000USD-854,000USD5,314,000USD
    Begin Period Cash Flow—17,328,000USD10,641,000USD7,037,000USD5,435,000USD6,221,000USD7,086,000USD5,478,000USD
    End Period Cash Flow—12,157,000USD17,328,000USD10,641,000USD7,037,000USD5,435,000USD6,221,000USD7,086,000USD
    Other Cashflows From Investing Activities—10,414,000USD5,075,000USD5,109,000USD49,000USD48,000USD105,000USD95,000USD
    Other Cashflows From Financing Activities—-10,000USD-10,000USD-699,000USD-67,000USD-43,000USD-719,000USD4,991,000USD
    Sale Purchase Of Stock——-65,000USD-55,000USD-52,000USD-9,000USD-68,000USD-93,000USD
    Investments———4,679,000USD-317,000USD-1,143,000USD-567,000USD-2,009,000USD
    Unclassified Investing Cash Flow———-4,679,000USD—1,143,000USD—2,009,000USD
    Issuance Of Capital Stock——————0USD—
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income4,973,000USD-16,449,000USD660,000USD-8,485,000USD-4,849,000USD-7,023,000USD-8,221,000USD
    Depreciation5,223,000USD4,224,000USD3,174,000USD1,292,000USD1,332,000USD2,079,000USD3,143,000USD
    Stock Based Compensation2,892,000USD4,117,000USD2,739,000USD2,464,000USD2,209,000USD1,084,000USD515,000USD
    Other Non Cash Items2,504,000USD1,540,000USD-10,553,000USD2,199,000USD954,000USD6,402,000USD5,746,000USD
    Change To Account Receivables-591,000USD-755,000USD-8,736,000USD-3,941,000USD-319,000USD2,890,000USD-647,000USD
    Change To Inventory-1,999,000USD-2,494,000USD-1,886,000USD-1,152,000USD2,624,000USD-5,792,000USD692,000USD
    Change In Working Capital-3,046,000USD-5,349,000USD-3,634,000USD-2,811,000USD793,000USD-3,273,000USD-2,554,000USD
    Total Cash From Operating Activities12,546,000USD-11,896,000USD-9,515,000USD-5,341,000USD439,000USD-731,000USD-413,000USD
    Capital Expenditures-2,382,000USD-4,113,000USD-1,456,000USD-1,764,000USD-2,115,000USD-1,545,000USD-879,000USD
    Free Cash Flow10,164,000USD-16,009,000USD-10,971,000USD-7,105,000USD-1,676,000USD-2,276,000USD-1,292,000USD
    Total Cashflows From Investing Activities7,899,000USD-3,730,000USD-24,784,000USD-1,559,000USD-1,890,000USD-1,304,000USD-544,000USD
    Net Borrowings-9,330,000USD12,433,000USD6,180,000USD-241,000USD-592,000USD-471,000USD-603,000USD
    Total Cash From Financing Activities-9,570,000USD16,073,000USD19,691,000USD9,020,000USD17,497,000USD-861,000USD-603,000USD
    Sale Purchase Of Stock-65,000USD—-261,000USD9,311,000USD-201,000USD620,000USD—
    Change In Cash11,107,000USD298,000USD-14,584,000USD2,120,000USD16,046,000USD-2,896,000USD-1,560,000USD
    Begin Period Cash Flow6,221,000USD5,923,000USD20,507,000USD18,387,000USD2,341,000USD5,237,000USD6,797,000USD
    End Period Cash Flow17,328,000USD6,221,000USD5,923,000USD20,507,000USD18,387,000USD2,341,000USD5,237,000USD
    Other Cashflows From Investing Activities10,281,000USD383,000USD175,000USD205,000USD225,000USD241,000USD335,000USD
    Other Cashflows From Financing Activities-175,000USD-816,000USD-500,000USD-1,559,000USD-337,000USD-1,010,000USD-148,000USD
    Investments—-3,730,000USD-22,893,000USD-1,559,000USD-1,890,000USD-1,304,000USD-544,000USD
    Issuance Of Capital Stock—4,456,000USD16,981,000USD9,311,000USD18,426,000USD620,000USD0USD
    Unclassified Investing Cash Flow—3,730,000USD—1,559,000USD1,890,000USD1,304,000USD—
    Unclassified Operating Cash Flow——-1,901,000USD————
    Unclassified Financing Cash Flow——14,272,000USD1,509,000USD18,828,000USD——
    Change To Liabilities———2,021,000USD-332,000USD-411,000USD-2,803,000USD
    Cash And Cash Equivalents Changes———2,120,000USD—-2,896,000USD-1,560,000USD
    Dividends Paid————-201,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. TTM requires four complete quarters. Missing values are not zero. Charts use rounded labels; expand values and sources for exact amounts. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.